On May 23, Invo Bioscience Got Notice As Of May 22 Co's Common Stock Subject To Delisting From Nasdaq Unless Co Requests Hearing Before Nasdaq Panel
Portfolio Pulse from Happy Mohamed
Invo Bioscience received a notice on May 23 that its common stock is subject to delisting from Nasdaq as of May 22, unless the company requests a hearing before a Nasdaq panel.
May 30, 2023 | 8:26 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Invo Bioscience's common stock is subject to delisting from Nasdaq, which may negatively impact its stock price in the short term.
Invo Bioscience received a notice that its common stock is subject to delisting from Nasdaq. This news is directly related to the company and may cause uncertainty among investors, leading to a potential negative impact on its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100